Haiwen Huang

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Qian Wang, Yibin Jiang, Qian Zhu, Yishan Duan, Xiaochen Chen, Ting Xu, Zhengming Jin, Caixia Li, Depei Wu, Haiwen Huang
Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma. Journal of cancer research and clinical oncology 147 (11) (2021)

Haiwen Huang.css-eqlu8i{font-size:small;padding-left:4px;}